{"id":799,"date":"2013-09-01T12:00:00","date_gmt":"2013-09-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/impfung-gegen-das-humane-papillom-virus-ein-zwischenbericht"},"modified":"2013-09-01T12:00:00","modified_gmt":"2013-09-01T10:00:00","slug":"impfung-gegen-das-humane-papillom-virus-ein-zwischenbericht","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/impfung-gegen-das-humane-papillom-virus-ein-zwischenbericht","title":{"rendered":"Impfung gegen das Humane Papillom-Virus \u2013 ein Zwischenbericht"},"content":{"rendered":"<p>Zusammenfassung: 2007 wurden die beiden Impfstoffe gegen Humane Papillom-Viren (HPV), Gardasil\u00ae (quadrivalent) und Cervarix\u00ae (bivalent), f\u00fcr junge M\u00e4dchen vor den ersten Sexualkontakten empfohlen. Die Centers for Disease Control and Prevention (CDC) haben 2011 in den USA auch eine entsprechende Empfehlung f\u00fcr junge M\u00e4nner gegeben. Die seither publizierten Studien- und Registerdaten zeigen einen hohen Schutz durch [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: 2007 wurden die beiden Impfstoffe gegen Humane Papillom-Viren (HPV), Gardasil\u00ae (quadrivalent) und Cervarix\u00ae (bivalent), f\u00fcr junge M\u00e4dchen vor den ersten Sexualkontakten empfohlen. Die Centers for Disease Control and Prevention (CDC) haben 2011 in den USA auch eine entsprechende Empfehlung f\u00fcr junge M\u00e4nner gegeben. Die seither publizierten Studien- und Registerdaten zeigen einen hohen Schutz durch [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2093,2095,2097,2094,2096,2101,2100,2102,2098,1455,2099,2092,2091,2090],"class_list":["post-799","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-cin","tag-condylomata-acuminata","tag-feigwarzen","tag-future-i-studie","tag-future-ii-studie","tag-genitalwarzen","tag-hpv","tag-hpv-impfung","tag-humanes-papillom-virus","tag-impfung","tag-patricia-studie","tag-warzen","tag-zervikale-intraepitheliale-neoplasien","tag-zervixkarzinom"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=799"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/799\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}